Home > Insider Trading > Filing (0001179110-14-017146)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1235010	Momenta Pharmaceuticals Inc	MNTA	Biological Products, (No Disgnostic Substances) (2836)	043561634

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1229450	A Craig Wheeler	C/O Momenta Pharmaceuticals, Inc. 675 West Kendall Street Cambridge MA 02142	President	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-11-25	2,210	$11.59	281,130	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	183,539	Indirect	Craig Wheeler Revocable Trust
Common Stock	150,000	Indirect	Craig A. Wheeler 2014 Irrevocable Trust

Footnotes

This sale was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on February 13, 2012.
This transaction was executed in multiple trades at prices ranging from $11.58 to $11.60. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Reflects a decrease of 81,433 shares held by the Craig Wheeler Revocable Trust that were previously incorrectly reported as being directly held by Mr. Wheeler.
Reflects (i) a decrease of 150,000 shares contributed to the Craig A. Wheeler 2014 Irrevocable Trust, a Grantor Retained Annuity Trust, on November 24, 2014 and (ii) an increase of 81,433 shares that were previously incorrectly reported as being directly held by Mr. Wheeler.